| Entry |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Meropenem (USP); Meropenem hydrate (JP18); Merrem (TN) | ||||||||||
| Product | MERREM (Pfizer Laboratories Div Pfizer), MEROPENEM AND SODIUM CHLORIDE (B. Braun Medical) | ||||||||||
| Generic | MEROPENEM (Amneal Pharmaceuticals LLC), MEROPENEM (AuroMedics Pharma LLC), MEROPENEM (BROOKS STERISCIENCE LIMITED), MEROPENEM (BluePoint Laboratories), MEROPENEM (BluePoint Laboratories), MEROPENEM (Civica), MEROPENEM (Daewoong America), MEROPENEM (Fresenius Kabi USA), MEROPENEM (Fresenius Kabi USA), MEROPENEM (Fresenius Kabi USA), MEROPENEM (Gland Pharma Limited), MEROPENEM (Hospira), MEROPENEM (Sandoz), MEROPENEM (Savior Lifetec Corporation), MEROPENEM (WG Critical Care), MEROPENEM (WG Critical Care), MEROPENEM (Xellia Pharmaceuticals USA LLC) | ||||||||||
| Formula | C17H25N3O5S. 3H2O | ||||||||||
| Exact mass | 437.1832 | ||||||||||
| Mol weight | 437.5083 | ||||||||||
| Structure |  | ||||||||||
| Simcomp | |||||||||||
| Class | Antibacterial DG01710 beta-Lactam antibiotic DG01713 Penicillin skeleton group DG01458 Carbapenem | ||||||||||
| Remark |
| ||||||||||
| Efficacy | Antibacterial, Cell wall biosynthesis inhibitor | ||||||||||
| Target | penicillin binding protein | ||||||||||
| Pathway |
| ||||||||||
| Interaction | |||||||||||
| Brite | Anatomical Therapeutic Chemical (ATC) classification [BR:br08303] J ANTIINFECTIVES FOR SYSTEMIC USE J01 ANTIBACTERIALS FOR SYSTEMIC USE J01D OTHER BETA-LACTAM ANTIBACTERIALS J01DH Carbapenems J01DH02 Meropenem D02222 Meropenem (USP) <JP/US> USP drug classification [BR:br08302] Antibacterials Carbapenems Meropenem D02222 Meropenem (USP) Therapeutic category of drugs in Japan [BR:br08301] 6 Agents against pathologic organisms and parasites 61 Antibiotics 613 Acting mainly on gram-positive and gram-negative bacteria 6139 Others D02222 Meropenem (USP); Meropenem hydrate (JP18) Drug groups [BR:br08330] Antibacterial DG01710 beta-Lactam antibiotic DG01713 Penicillin skeleton group DG01458 Carbapenem DG00591 Meropenem D02222 Meropenem Drug classes [BR:br08332] Antibacterial DG01458 Carbapenem D02222 Meropenem Antimicrobials [BR:br08307] Antibacterials Cell wall biosynthesis inhibitor, beta-lactam Carbapenem D02222 Meropenem (USP) <JP/US> Drugs listed in the Japanese Pharmacopoeia [BR:br08311] Chemicals D02222 Meropenem hydrate D02222 Meropenem for injection Drug groups [BR:br08330] Antibacterial DG01710 beta-Lactam antibiotic DG01713 Penicillin skeleton group DG01458 Carbapenem DG00591 Meropenem Antimicrobials abbreviations [BR:br08327] Antibacterials Cell wall biosynthesis inhibitor, beta-lactam Carbapenem DG00591 Meropenem | ||||||||||
| Other DBs |
| ||||||||||
| KCF data | ATOM 29 1 O0 O 40.8797 -17.2898 2 C1y C 31.1834 -17.6345 3 C1y C 24.8446 -15.7533 4 C5x C 24.8446 -17.1109 5 N1y N 26.1343 -17.1109 6 C1y C 26.1343 -15.7533 7 C2y C 27.4240 -17.5181 8 C2y C 28.2386 -16.4321 9 C1y C 27.4240 -15.3460 10 C6a C 27.8314 -18.8078 11 O6a O 29.1889 -18.8078 12 O6a O 27.0846 -19.8939 13 S2a S 30.4892 -16.4321 14 C1a C 27.8391 -14.0535 15 C1c C 23.6337 -15.0541 16 C1a C 22.4227 -15.7533 17 O5x O 23.6337 -17.8100 18 O1a O 23.6340 -13.6404 19 C1x C 30.7741 -18.9693 20 N1x N 31.9171 -19.7698 21 C1y C 33.0317 -18.9303 22 C1x C 32.5774 -17.6107 23 C5a C 34.4193 -18.9303 24 O5a O 35.1191 -20.1423 25 C1a C 36.5186 -17.7183 26 N1c N 35.1191 -17.7183 27 C1a C 34.4209 -16.5088 28 O0 O 40.8797 -17.2898 29 O0 O 40.8797 -17.2898 BOND 28 1 3 4 1 2 4 5 1 3 5 6 1 4 3 6 1 5 5 7 1 6 7 8 2 7 8 9 1 8 6 9 1 9 7 10 1 10 10 11 1 11 10 12 2 12 8 13 1 13 9 14 1 #Up 14 3 15 1 15 15 16 1 16 4 17 2 17 15 18 1 #Up 18 2 13 1 #Up 19 2 19 1 20 19 20 1 21 20 21 1 22 21 22 1 23 2 22 1 24 21 23 1 #Up 25 23 24 2 26 25 26 1 27 23 26 1 28 26 27 1 BRACKET 1 38.8500 -18.4100 38.8500 -16.2400 1 41.4400 -16.2400 41.4400 -18.4100 1 3 ORIGINAL 1 1 REPEAT 1 30 31 |